Transport for biological material helps Cellbox raise a €5 million Series A
Cellbox Solutions closed its Series A at €5 million following an initial closing of approximately €3.5 million in March 2026. New investors including Baltic Business Angels Invest GmbH joined existing backers NRW.BANK and Fraunhofer Venture. The company plans to expand its warm-chain technology platform into broader physiological logistics solutions and strengthen its international market presence, serving the cell-therapy and life sciences sectors.
Key points
- Cellbox Solutions raises €5 million Series A for warm-chain logistics expansion
- Funding follows €3.5 million initial closing in March 2026
- Platform supports transport of sensitive biological materials for cell-therapy sector
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. EU-Startups did the reporting; read the original for the full story.
Read the full story at EU-Startups
